Search Within

Madhu Mazumdar

Formats
  1. Journal Article (104)
  2. Meeting Abstract (21)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (86)
  3. Genitourinary Oncology Service (70)
  4. Surgery (61)
  5. Survivorship Research (50)
  6. Radiology, Department of (31)

More Groups

People
  1. Robert Motzer (48)
  2. Dean Bajorin (41)
  3. George Bosl (30)
  4. Jennifer Bacik (26)
  5. Vaia Vlamis (20)
  6. Jose Guillem (17)

More People

Years
  1. 2013 (1)
  2. 2012 (1)
  3. 2011 (2)
  4. 2007 (2)
  5. 2006 (2)
  6. 2005 (9)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Annals of Surgical Oncology (8)
  3. Cancer (6)
  4. Investigational New Drugs (6)
  5. Statistics in Medicine (6)
  6. Annals of Surgery (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (48)
  2. Springer (17)
  3. American Association for Cancer Research (8)
  4. Elsevier Science, Inc. (8)
  5. Wiley Blackwell (8)
  6. Lippincott Williams & Wilkins (7)

More Publishers

Results (127)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors
    Journal Article

    Motzer, R. J.; Mazumdar, M.; Gulati, S. C.; Bajorin, D. F.; Lyn, P.; Vlamis, V.; Bosl, G. J.
    JNCI: Journal of the National Cancer Institute (1993)

    Fulltext@MSK | Save
  • Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up
    Journal Article

    Minasian, L. M.; Motzer, R. J.; Gluck, L.; Mazumdar, M.; Vlamis, V.; Krown, S. E.
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study
    Journal Article

    Bajorin, D. F.; Sarosdy, M. F.; Pfister, D. G.; Mazumdar, M.; Motzer, R. J.; Scher, H. I.; Geller, N. L.; Fair, W. R.; Herr, H.; Sogani, P.; more...
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer
    Journal Article

    Kelly, W. K.; Scher, H. I.; Mazumdar, M.; Vlamis, V.; Schwartz, M.; Fossa, S. D.
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Allelic deletions in renal tumors: Histopathological correlations
    Journal Article

    Presti, J. C. Jr; Reuter, V. E.; Cordon-Cardo, C.; Mazumdar, M.; Fair, W. R.; Jhanwar, S. C.
    Cancer Research (1993)

    Fulltext@MSK | Save
  • Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors
    Journal Article

    Motzer, R. J.; Gulati, S. C.; Tong, W. P.; Menendez-Botet, C.; Lyn, P.; Mazumdar, M.; Vlamis, V.; Lin, S.; Bosl, G. J.
    Cancer Research (1993)

    Fulltext@MSK | Save
  • Infiltrating breast carcinoma in patients age 30 years and younger: Long term outcome for life, relapse, and second primary tumors
    Journal Article

    Lee, C. G.; McCormick, B.; Mazumdar, M.; Vetto, J.; Borgen, P. I.
    International Journal of Radiation Oncology, Biology, Physics (1992)

    Fulltext@MSK | Save